SciBac, Inc.
PrivateLast Round
Grant
Jul 31, 2018
Total Funding Raised
$1.03M
Company Overview
SciBac, Inc. is a biotechnology company that develops live biotherapeutics designed to treat antibiotic-resistant infections by fortifying the human microbiome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SciBac, Inc. Comparables
Compare SciBac, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vedanta Biosciences | 81% | |
| Osel Inc. | 81% | |
| Exeliom Biosciences | 78% | |
SciBac, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 31, 2018 | ||||
| Accelerator | Apr 13, 2017 |
SciBac, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 31, 2018
$680K grant received from CARB-X.
- Apr 13, 2017
$350K raised from Breakout Labs.
SciBac, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SciBac, Inc.'s valuation, stock price, and market status.